Permite Cream

Quick links to important sections

Permite Cream

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Permite Cream

Permite Cream is a monosemantic pharmaceutical preparation intended for topical application to the skin. It belongs to the high-level pharmacological class of antiparasitic agents, specifically defined as both an ectoparasiticide and a scabicide.

Property Description
Active ingredient Permethrin
Form Cream (semi-solid emulsion)
Pharmacological class Antiparasitic agent, Ectoparasiticide
Common use Elimination of parasitic infestations
Origin Synthetic pyrethroid

What Type of Medicine is Permite Cream?

Permite Cream is primarily categorized as an ectoparasiticide, a drug type used to eliminate parasites (ectoparasites) that live on the surface of the human body, such as mites and lice. Its designation as a scabicide specifically confirms its critical role in addressing infestations caused by the Sarcoptes scabiei mite. The product's dosage form is a cream, which is a semi-solid emulsion vehicle suitable for effective dermal application across affected areas. Permethrin is clinically recognized as an agent used to treat parasitic conditions like scabies and lice. The medication's primary goal is parasitic eradication.


Permethrin: Composition and Synthetic Origin

The active ingredient in Permite Cream is Permethrin, a potent compound defined as a synthetic pyrethroid. This substance is chemically engineered in a laboratory to emulate the structure and function of pyrethrins, which are the naturally occurring insecticides found in chrysanthemum flowers. This specific composition is designed for its indicated use.

Because Permethrin is synthetically derived, it possesses enhanced chemical stability and a reliable profile of activity compared to its natural counterparts. This composition, in the specific cream base of Permite Cream, ensures the drug's role as an effective acaricide and insecticide, targeting parasites by interfering with their neural functions upon topical administration.


General Purpose of an Antiparasitic Cream

The general therapeutic purpose of this preparation is to resolve skin infestations by acting as a highly specific neurotoxin against target organisms. Permethrin achieves this by binding to the sodium channels in the nerve cell membranes of the parasites, which results in continuous stimulation and subsequent paralysis. By facilitating this targeted antiparasitic action on the skin surface, the medication effectively interrupts the parasite's life cycle and addresses the underlying cause of the condition, such as irritation and itching resulting from a typical scabies infestation.

Regulatory References

  1. MedlinePlus Drug Information on Permethrin

What side effects are possible with Permite Cream?

The documented safety characteristics and adverse reactions associated with the use of Permite Cream (Permethrin 5% cream) are classified based on official government regulatory documents, focusing primarily on application-site reactions.

Application-Site Reactions and Frequency

Adverse reactions are predominantly classified within Skin and Subcutaneous Tissue disorders. The most common reactions reported in official labeling include burning and stinging, which are typically mild and transient, along with pruritus (itching), erythema (redness), and changes such as numbness or tingling at the site of application. Regulatory documents note that the treatment may temporarily exacerbate existing symptoms of the underlying infestation, such as pruritus and edema.

Time-Related Safety Patterns

A specific pattern noted in regulatory documentation is that pruritus may persist for up to four weeks following the completion of the treatment course. This persistence is generally regarded as a reaction to the dead mites and not an indication of treatment failure, distinguishing it from an ongoing adverse reaction.

Other Reported Reactions and Constraints

Systemic events such as headache, dizziness, nausea, and vomiting have been reported in post-marketing surveillance with a Frequency Not Known.

The cream is officially contraindicated in individuals with known hypersensitivity to the active ingredient, permethrin, any synthetic pyrethroid, or pyrethrin. Regulatory safety guidance also indicates that the safety and efficacy have not been established in infants younger than 2 months of age. Furthermore, use of the cream may worsen existing symptoms in patients with conditions such as asthma or eczema, as defined in the official labeling.

Overdose and Emergency Response

Overdose and When to Seek Help: Official Regulatory Information

The official overdose information for Permite Cream is defined by government regulatory documents and primarily addresses the risk associated with accidental ingestion of the topical cream, as topical absorption is minimal. Severe outcomes are explicitly linked to oral consumption.


Documented Manifestations and Severe Outcomes

Accidental ingestion may result in systemic effects that include nausea, vomiting, loss of appetite, dizziness, headache, and weakness. The most severe outcomes documented in regulatory labeling include seizures and loss of consciousness.

Overdose Presentation Severe Outcome Supportive Measure
Nausea, Vomiting, Dizziness Seizures Symptomatic Treatment
Weakness, Headache Loss of Consciousness Gastric Lavage (Consideration)*

*Gastric lavage may be considered for a child if ingestion is reported within two hours of consultation.


Mandatory Urgent Actions

In the event of suspected overdose or accidental ingestion, seek immediate medical attention. Regulators mandate contacting a Poison Control Center or a physician immediately for guidance. If the person has collapsed or is not breathing, contact emergency medical services immediately. Treatment is defined as symptomatic, as no specific antidote is officially documented in the prescribing information.

Therapeutic Uses of Permite Cream

Main uses of Permite Cream

Permite Cream is a topical medication primarily used for the treatment of infestations caused by specific external parasites. Its active ingredient, permethrin, belongs to a class of medications known as pyrethrins, which function as neurotoxins to eliminate the organisms responsible for the skin condition.

Treatment of Scabies

The most common application for Permite Cream is the treatment of scabies. Scabies is a skin infestation caused by the microscopic mite Sarcoptes scabiei. These mites burrow into the upper layer of the skin to live and deposit eggs, leading to intense itching and a pimple-like skin rash.

Permite Cream works by disrupting the nervous system of the mites, leading to paralysis and death of both the adult mites and their eggs. This intervention is designed to stop the reproductive cycle of the parasite and clear the infestation from the body.

Benefits of Treatment

  • Eradication of Parasites: The primary benefit of the cream is its high efficacy rate in eliminating the mites responsible for scabies, typically requiring only a single thorough application to resolve the infestation.
  • Relief from Symptoms: By removing the source of the infestation, the cream facilitates the eventual cessation of the persistent itching and skin irritation associated with the mite's presence.
  • Prevention of Transmission: Successful treatment of the individual helps to prevent the further spread of the parasites to close contacts and family members, as scabies is highly contagious through direct skin-to-skin contact.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Eligibility Map: Who can and Cannot Use Permite Cream

The eligibility for Permite Cream (Permethrin 5% cream) is defined by strict regulatory guidelines established by authorities such as the FDA and EMA. The information below summarizes the official population eligibility and non-eligibility rules.


Absolute Contraindications

Use is contraindicated in patients with known hypersensitivity to the active ingredient, permethrin, any of the cream's components, or related substances like synthetic pyrethroids or pyrethrins.


Age-Related Eligibility and Restrictions

Age Group Eligibility Status (Regulatory Wording)
Infants (< 2 months) Safety and effectiveness have not been established (FDA/DailyMed).
Children (≥ 2 months) Permitted for use (DailyMed).
Children (2–23 months) Treatment must be given only under close medical supervision (EMA/SmPC).
Adults & Older Adults Permitted for use; no special precautions are deemed necessary.

Special Population and Condition-Specific Status

Population Status Regulatory Guidance (Official Labeling)
Pregnancy Status Classified as Pregnancy Category B; use should occur only if clearly needed.
Lactation Status Not known whether this drug is excreted in human milk; consideration should be given to temporarily discontinuing nursing.
Comorbidity (Allergy) Patients with known allergy to chrysanthemums or Compositae should only use the cream if strictly indicated.

The regulatory profile thus defines a clear minimum age threshold of two months and absolute non-eligibility based on hypersensitivity.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

This section summarizes the officially documented interactions for Permite Cream (Permethrin), strictly based on government regulatory labeling. The cream is applied topically, and its active ingredient, Permethrin, is minimally absorbed into the bloodstream (typically less than 2%).

Systemic Drug Interactions

Due to this minimal systemic exposure, regulatory authorities conclude that no clinically significant interactions are known or expected with other systemic (oral or injectable) medicines, including enzyme- or transporter-mediated interactions.

Documented Topical and Excipient Interactions

Official labeling documents specific cautions related to co-application of other topical agents and excipient interference:

  • Topical Corticosteroids: The use of topical corticosteroids to treat associated skin reactions should be withheld prior to treatment with Permite Cream. This is to avoid suppressing the local immune response, which could mask or potentially exacerbate the underlying parasitic infestation.
  • Latex Products: The excipients (inactive ingredients) in the cream base, such as paraffin, may reduce the functional integrity and reliability of latex barrier contraceptives (like condoms or diaphragms) if they are used concurrently with or shortly after the cream application.

Mechanism of Action

Selective Modulation of Arthropod Sodium Channels

The active ingredient operates by selective binding to Voltage-Gated Sodium Channels (VGSCs), which are ion channels on the nerve cell membranes of target parasites. This molecular interaction involves stabilizing the channel in its open state, a direct form of positive allosteric modulation that prevents its normal inactivation. The physiological consequence is the onset of uncontrolled, sustained Na^+ influx into the parasitic neuron.


Neurotoxic Cascade Leading to Paralysis

The continuous Na^+ influx and subsequent failure of nerve cell repolarization initiate a neurotoxic cascade. This molecular event translates into hyperexcitability and repetitive, uncontrolled firing within the parasite's nervous system. The excessive neural signaling ultimately induces muscular spasms, causing flaccid paralysis and subsequent systemic collapse of the organism.


Constraints on Mechanistic Efficacy

The core mechanism is limited by genetic modifications in some parasite populations. Specific mutations in the VGSC gene, known as kdr mutations, alter the drug's binding site, leading to target-site insensitivity. This structural change weakens the Permethrin-channel interaction, preventing the full neurotoxic cascade and resulting in reduced mortality of the organism.

Dosage and Administration Information

How to Use Permite Cream: Official Administration Guidelines

Permite Cream (Permethrin 5% w/w) is a pharmaceutical preparation intended exclusively for topical administration to the skin. The application process is generally structured around a single, time-bound course, defining the specific areas of coverage and contact duration required for proper use.


Administration Protocol

The cream is applied to clean, dry, cool skin and must be thoroughly massaged into the surface. The standard protocol requires the cream to be applied to the entire body from the neck to the soles of the feet. The required contact time is strictly defined: the cream must remain on the skin for 8 to 14 hours, after which it must be removed by taking a bath or shower.

Classification Instruction Pattern
Route of Administration Topical (Cutaneous) use only
Frequency Pattern Single-course application; Intermittent re-treatment only if live mites persist, typically separated by 7 to 14 days

Dosing and Population Adjustments

Adults and Adolescents (over 12 years) are typically instructed to use up to 30 grams of the cream for the full-body application. For children, the labeled dosing ranges are lower, with those aged 6 to 12 years requiring up to 15 grams, and children 1 to 5 years requiring up to 7.5 grams.

Administration rules are adjusted for specific populations: for infants (2 months to 2 years) and older adults, application must also cover the scalp, face, ears, and neck. If the hands are washed during the 8- to 14-hour contact period, the cream must be immediately reapplied to the hand and wrist area to maintain full coverage.

Recent Clinical Evidence

Research evidence / Overview of studies for Permite Cream

Evidence for Use in Scabies Infestation

Permite Cream was studied for its use in infestations caused by the Sarcoptes scabiei mite. Research examined how symptoms, such as intense itching, were measured over time. The research relies primarily on Randomized Controlled Trials (RCTs) and summaries of these findings known as Systematic Reviews and Meta-analyses. These studies examined patients over short to intermediate follow-up periods, typically between two and eight weeks after treatment.

The main outcomes related to physical discomfort that researchers monitored were the measurement of parasitic clearance in the studies, including mites and lesions, and the measurement of pruritus (itching) severity. Findings describe patterns observed in the studies, where the measurement of itching severity was studied alongside the measurement of parasitic clearance.

Evidence for Use in Lice Infestation (Pediculosis)

For head lice and pubic lice infestations, the research was evaluated in Randomized Controlled Trials (RCTs) and studies comparing Permite Cream against other lice treatments. Research explored short-term outcomes related to physical discomfort, with most follow-up durations being limited to one or two weeks.

Research for Crusted Scabies (Severe Form)

Evidence related to the severe form of the condition, known as crusted scabies, is limited because controlled efficacy data from RCTs for Permite Cream as a single treatment is unavailable. Evidence was observed in Case Series and Observational Studies only, where studies monitored changes in the severe skin lesions and mite clearance.

What is Still Uncertain About Permite Cream Evidence

The available evidence highlights what is known—and what is still uncertain—about the use of Permite Cream. Evidence quality varies across studies, with some older trials having less rigorous reporting. A significant area of uncertainty is associated with the increasing reports of parasite resistance to permethrin in various regions, which may impact the expected clearance rate. Furthermore, comparative evidence is lacking for certain severe forms of the condition, making subgroup findings are not fully established. The study results reflect the specific conditions under which they were conducted and research provides context but not individual predictions.

Key Studies & References

  1. Label: PERMETHRIN- permethrin cream 5% w/w cream - DailyMed (Used for FDA-approved indication and age limit for scabies)

Frequently Asked Questions (FAQ)

Common questions about Permite Cream (FAQ)

Q: How long does the itching last after I use Permite Cream?

A: Official information indicates that pruritus (itching) may persist for up to four weeks after the treatment course. This post-treatment persistence is generally understood to be a reaction to the dead mites. If symptoms persist or worsen, it is important to consult a healthcare provider.

Q: What are the common side effects of Permite Cream, and when should I worry?

A: Common application-site reactions reported in regulatory documents include burning and stinging, itching, redness, numbness, and tingling. Systemic events such as headache, dizziness, and nausea have also been reported, though their frequency is not known. The cream is contraindicated (should not be used) in individuals who have a known hypersensitivity to the active ingredient, permethrin.

Q: Why is Permite Cream toxic to the environment, and how do I throw out the unused portion?

A: Permite Cream should not be released to the environment or poured into drains or waterways because official safety guidance indicates it is toxic to aquatic life. For proper disposal, unused or expired cream should be handled in accordance with local and national regulations, which often require submission to an approved waste disposal facility.

Q: How much Permite Cream should I use, and for how long do I leave it on?

A: According to the official product information, the cream must remain on the skin for a contact time of 8 to 14 hours before being washed off with a bath or shower. Specific dosing guidance, including the exact amount needed, is available in the 'How to Use' section of the product labeling.

Q: Can I drink alcohol while I am treating a scabies infestation with Permite Cream?

A: Official documentation reports that because the active ingredient is minimally absorbed into the bloodstream, no clinically significant interactions are known or expected with other systemic (oral or injectable) medicines. However, it is always recommended to discuss any consumption of alcohol with a healthcare professional.

How should Permite Cream be stored and disposed of?

The official storage and disposal guidelines for Permethrin Cream 5% prioritize product stability and safety.

Storage Requirements

The cream must be stored at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F). It is essential to keep the product from freezing and to protect it from excess heat and moisture. Store the cream in its original container and ensure the cap is kept tightly closed.

Crucially, the medication must be stored out of the sight and reach of children.

Disposal Instructions

Any unused or expired cream must be disposed of in accordance with local and national regulations, often requiring submission to an approved waste disposal facility. Due to its toxicity to aquatic life, the product must not be released to the environment or disposed of by pouring it into drains or waterways.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Permite Cream found in:

A-Z Index: